Patent details

EP2371391 Title: Therapeutic use of anti-CS1 antibodies

Basic Information

Publication number:
EP2371391
PCT Application Number:
Type:
European Patent Granted for LU
Legal Status:
Expired
Application number:
EP101833770
PCT Publication Number:
First applicant's nationality:
Translation Language:
EPO Publication Language:
English
English Title of Invention:
Therapeutic use of anti-CS1 antibodies
French Title of Invention:
Utilisation thérapeutique d'anticorps anti-CS1
German Title of Invention:
Therapeutische Verwendung von Anti-CS1-Antikörpern
SPC Number:
93274

Dates

Filing date:
10/05/2004
Grant date:
23/07/2014
EP Publication Date:
23/07/2014
PCT Publication Date:
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
05/10/2011
EP B1 Publication Date:
23/07/2014
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
Expiration date:
10/05/2024
Renunciation date:
Revocation date:
Annulment date:

Owner

From:
10/05/2004
 
 

Name:
AbbVie Biotherapeutics Inc.
Address:
1500 Seaport Boulevard, Redwood City, CA 94063, United States (US)

Agent

Name:
DENNEMEYER & ASSOCIATES S.A. PATENT DEPARTMENT
From:
15/10/2014
Address:
PO Box 1502, 1015, LUXEMBOURG, Luxembourg (LU)
To:

Inventor

1

Name:
Powers David B.
Address:
United States (US)

2

Name:
Liu Gao
Address:
United States (US)

3

Name:
Tso Yun J.
Address:
United States (US)

4

Name:
Williams Marna
Address:
United States (US)

5

Name:
Landolfi Nicolas F.
Address:
United States (US)

Priority

1

Priority Number:
469211 P
Priority Date:
08/05/2003
Priority Country:
United States (US)

2

Priority Number:
557620 P
Priority Date:
29/03/2004
Priority Country:
United States (US)

3

Priority Number:
557621 P
Priority Date:
29/03/2004
Priority Country:
United States (US)

4

Priority Number:
557622 P
Priority Date:
29/03/2004
Priority Country:
United States (US)

Classification

Main IPC Class:
A61K 39/395;

Annual Fees

Annual Fee Due Date:
Annual Fee Number:
Expected Payer:
Last Annual Fee Payment Date:
26/04/2023
Last Annual Fee Paid Number:
20
Last Annual Fee Paid Amount:
300 Euro
Payer:
MASTER DATA CENTER INC (ex Clarivate Analytics)
Filing date Document type Number of pages